Procabazine induced oxidative haemolysis: relationship in vivo red cell survival.
D002470:Cell Survival; D002860:Chromium Radioisotopes; D004912:Erythrocytes / Q000378:metabolism*; D005955:Glucosephosphate Dehydrogenase Deficiency; D005978:Glutathione / Q000097:blood; D006461:Hemolysis / Q000187:drug effects*; D006801:Humans; D006835:Hydrazones / Q000494:pharmacology; D006861:Hydrogen Peroxide / Q000096:biosynthesis; D066298:In Vitro Techniques; D008706:Methemoglobin; D009369:Neoplasms / Q000188:drug therapy; D009996:Osmotic Fragility / Q000187:drug effects; D010084:Oxidation-Reduction; D011344:Procarbazine / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D013329:Structure-Activity Relationship
D002860:Chromium Radioisotopes; D006835:Hydrazones; D011344:Procarbazine; D008706:Methemoglobin; D006861:Hydrogen Peroxide; D005978:Glutathione